Introduction Series One Summary
General practice assessment and review examination review to analyze practice needs and advance practice in regenerative nanomedicine.
Comprehensive concepts and presentation of the new FDA regulations and guidelines for autologous and homologous use.
How to practice safe regenerative nanomedicine and address advances in extracellular vesicles nano particles and MSCs. Clinical applications have reported in literature on immune modulation & defense, viruses, brain disorders, pulmonary, joint regeneration, burn & wound care, cosmetic, pain, senescence and more. Acceptable consent forms and pricing examples. More in Series Three.
Presentations by tissue banks that have high standards, efficacy, safety and have passed RichSource’s personal testing and review. Each tissue bank and biolab will cover procurement material screenings, high quality brand development, current stages of processing and science, advances in therapeutic applications and treatment outcomes, IRB and IND filings.
Q & A with tissue bank CSO, COO or MD. Integration with PRP therapy.
Call or complete the CONTACT US so a RichSource Area VP can speak with you. CME accreditation pending.